Detalhe da pesquisa
1.
Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature.
Pathologica
; 116(1): 13-21, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38482671
2.
Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment Features.
Mod Pathol
; 36(2): 100012, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36853785
3.
HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer.
Oncologist
; 24(10): 1395-1402, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30952821
4.
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer.
Nature
; 486(7404): 532-6, 2012 Jun 28.
Artigo
Inglês
| MEDLINE | ID: mdl-22722830
5.
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer.
Br J Cancer
; 117(3): 347-352, 2017 Jul 25.
Artigo
Inglês
| MEDLINE | ID: mdl-28654634
6.
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.
Lancet Oncol
; 17(6): 738-746, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27108243
7.
Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer.
Br J Cancer
; 113(12): 1730-4, 2015 Dec 22.
Artigo
Inglês
| MEDLINE | ID: mdl-26633560
8.
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study.
Mod Pathol
; 28(11): 1481-91, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26449765
9.
Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers.
J Clin Pathol
; 2024 Feb 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38350716
10.
KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy.
Int J Cancer
; 133(5): 1259-65, 2013 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23404247
11.
Improved multiplex ligation-dependent probe amplification analysis identifies a deleterious PMS2 allele generated by recombination with crossover between PMS2 and PMS2CL.
Genes Chromosomes Cancer
; 51(9): 819-31, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22585707
12.
DNA end resection by CtIP and exonuclease 1 prevents genomic instability.
EMBO Rep
; 11(12): 962-8, 2010 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-21052091
13.
Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients.
Cancer Discov
; 12(7): 1656-1675, 2022 07 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35522273
14.
Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial.
ESMO Open
; 5(5): e000911, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32988996
15.
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer.
Clin Colorectal Cancer
; 19(4): 256-262.e2, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32919890
16.
The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience.
Biomed Res Int
; 2019: 6832909, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31111063
17.
Combined Low Densities of FoxP3+ and CD3+ Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of Progression.
Cancer Immunol Res
; 7(5): 751-758, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30804005
18.
TRKA expression and NTRK1 gene copy number across solid tumours.
J Clin Pathol
; 71(10): 926-931, 2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-29802225
19.
Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer.
Cancer Cell
; 34(1): 148-162.e7, 2018 07 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29990497
20.
Identification and characterization of a novel SCYL3-NTRK1 rearrangement in a colorectal cancer patient.
Oncotarget
; 8(33): 55353-55360, 2017 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28903424